March 7th 2023
Novan’s expected PDUFA date is January 5, 2024.
February 18th 2023
Rosacea: Burden, the Role of Ceramides and the Microbiome in Treatment, and the Role of the Pharmacist
1 Credit / Dermatology
View More
The Essential Roles of Ceramides and the Skin Microbiome to Promote Skin Health
1 Credit / Dermatology
View More
JAK Inhibitors and the Evolving Treatment Landscape in Atopic Dermatitis and Alopecia Areata
1.0 Credit / Dermatology
View More
Advances in the Treatment of Non-Melanoma Skin Cancers: The Role of Immune Checkpoint Inhibitors
1.5 Credits / Dermatology, Oncology
View More
Management Considerations for Hidradenitis Suppurativa and the Emerging Role of Biologics in Treatment
2.0 Credits / Dermatology, Immunology
View More
Hidradenitis Suppurativa: Pharmacist Considerations for the Emerging Treatment Options
1.0 Credit / Dermatology, Immunology
View More
Treatment Advancements in Atopic Dermatitis With JAK Inhibitors: Updates for Pharmacists
0.5 Credit / Dermatology
View More
Exploring Treatment Advances in Plaque Psoriasis and the Role of the Pharmacist in Patient Outcomes
1.0 Credit / Dermatology
View More
Practical Approaches for Managing Moderate to Severe Pediatric Atopic Dermatitis: A Pharmacist’s Review of Novel Treatments and Caregiver Counseling Pearls
1.5 Credits / Dermatology, Immunology
View More
The Latest Advances in the Management of Atopic Dermatitis and the Role of JAK Inhibitors: Best Practices for the Pharmacist
0.5 Credit / Dermatology, Immunology
View More
Advances in the Management of Prurigo Nodularis: Updates for the Specialty Pharmacist
1.5 Credits / Dermatology, Immunology
View More
Overcoming the Challenges of Treating and Managing Moderate to Severe Atopic Dermatitis in Pediatric Patients
1.5 Credits / Dermatology, Immunology
View More
Therapy Advancements for Chronic Kidney Disease in Patients With Diabetes: A Focus on MRAs
1.5 Credits / Endocrinology, Nephrology
View More
JAK Inhibitors and Management of Atopic Dermatitis: A Comprehensive Activity for Pharmacists
1 Credit / Dermatology, Immunology
View More
Protecting the Skin Barrier to Prevent and Reduce Photosensitivity (Pharmacy Technician)
1 Credit / Dermatology
View More
Eczema: Burden, the Role of Ceramides and Prebiotics in Management, and the Role of the Pharmacist (Pharmacy Technician)
1 Credit / Dermatology
View More
Rosacea: Burden, the Role of Ceramides and the Microbiome in Treatment, and the Role of the Pharmacist (Pharmacy Technician)
1 Credit / Dermatology
View More
Acne: Burden, the Role of Ceramides and the Microbiome in Treatment and Prevention, and the Role of the Pharmacist (Pharmacy Technician)
1 Credit / Dermatology
View More
The Essential Roles of Ceramides and the Skin Microbiome to Promote Skin Health (Pharmacy Technician)
1 Credit / Dermatology
View More
Eczema: Burden, the Role of Ceramides and Prebiotics in Management, and the Role of the Pharmacist
1 Credit / Dermatology
View More
Protecting the Skin Barrier to Prevent and Reduce Photosensitivity
1 Credit / Dermatology
View More
Acne: Burden, the Role of Ceramides and the Microbiome in Treatment and Prevention, and the Role of the Pharmacist
1 Credit / Dermatology
View More
Rosacea: Burden, the Role of Ceramides and the Microbiome in Treatment, and the Role of the Pharmacist
1 Credit / Dermatology
View More
The Essential Roles of Ceramides and the Skin Microbiome to Promote Skin Health
1 Credit / Dermatology
View More
The Importance of Emerging JAK Inhibitors and Potential Place in Therapy for Atopic Dermatitis (On-Demand)
1 Credit / Managed Care
View More
Community Practice Connections™: Multidisciplinary Management of BPDCN: Strategies for Differential Diagnosis and Integrating Novel Targeted Therapy
View More
The Importance of Emerging JAK Inhibitors and Potential Place in Therapy for Atopic Dermatitis (On-Demand)
1 Credit / Managed Care
View More
JAK Inhibitors and the Evolving Treatment Landscape in Atopic Dermatitis and Alopecia Areata
1.0 Credit / Dermatology
View More
Medical Crossfire®: Diagnostic and Clinical Considerations in Cutaneous T-Cell Lymphoma for the Dermatologist and the Collaborative Cancer Team
View More
JAK Inhibitors and the Evolving Treatment Landscape in Atopic Dermatitis and Alopecia Areata
1.0 Credit / Dermatology
View More
Real-World Study Shows Dupixent Improves AD Symptoms in Children Under 12 Years
October 11th 2022A real-world study of children with moderate-to-severe atopic dermatitis (AD) in China found Dupixent can reduce symptoms and improve pruritus. Traditional therapies had little effect, according to the researchers.
The Latest Updates in Pediatric Dermatology
June 19th 2022Lisa Swanson, MD, sits down to discuss her recent presentation on pediatric dermatology featured at the 2022 SDPA Annual Summer Meeting held June 16-19, 2022, in Austin, Texas. She also describes her experience being the only pediatric dermatologist in Idaho.
Optimize Outcomes for Pediatric Patients Who Need Infusion Therapy
June 17th 2022Robert Dracker, MD, MHA, MBA, CPI discussed considerations and developmentally appropriate interventions to promote high quality, patient-centered pediatric infusion care in a presentation at the 2022 National Infusion Center Association Annual Conference.
Dupilumab's Impact on Quality of Life in Children 6 Months to 5 Years
April 11th 2022An abstract presented at the Revolutionizing Atopic Dermatitis conference discussed the impact of treatment with dupilumab on quality of life for children aged 6 months to 5 years with atopic dermatitis, as well as their caregivers.